Fundamental Uncertainty: Interplatform Inconsistency of FDA-Cleared Serological Tests

Journal Article Fundamental Uncertainty: Interplatform Inconsistency of FDA-Cleared Serological Tests Get access Mark A Cervinski Mark A Cervinski Director of Clinical Chemistry and Point-of-Care Testing, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, United StatesAssociate Professor of Pathology and Laboratory Medicine, Department of Pathology and Laboratory Medicine, The Geisel School of Medicine at Dartmouth, Hanover, NH, United States Address correspondence to this author at: Dartmouth Hitchcock Medical Center, Department of Pathology and Laboratory Medicine, 1 Medical Center Dr., Lebanon, NH 03766, United States. Tel 603-650-4975; E-mail mark.a.cervinski@hitchcock.org. https://orcid.org/0000-0001-5116-3780 Search for other works by this author on: Oxford Academic Google Scholar The Journal of Applied Laboratory Medicine, jfae053, https://doi.org/10.1093/jalm/jfae053 Published: 18 June 2024 Article history Received: 26 December 2023 Accepted: 29 April 2024 Published: 18 June 2024